BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28130400)

  • 1. Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST.
    Pantaleo MA; Urbini M; Indio V; Ravegnini G; Nannini M; De Luca M; Tarantino G; Angelini S; Gronchi A; Vincenzi B; Grignani G; Colombo C; Fumagalli E; Gatto L; Saponara M; Ianni M; Paterini P; Santini D; Pirini MG; Ceccarelli C; Altimari A; Gruppioni E; Renne SL; Collini P; Stacchiotti S; Brandi G; Casali PG; Pinna AD; Astolfi A; Biasco G
    Mol Cancer Res; 2017 May; 15(5):553-562. PubMed ID: 28130400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).
    Nannini M; Astolfi A; Urbini M; Indio V; Santini D; Heinrich MC; Corless CL; Ceccarelli C; Saponara M; Mandrioli A; Lolli C; Ercolani G; Brandi G; Biasco G; Pantaleo MA
    BMC Cancer; 2014 Sep; 14():685. PubMed ID: 25239601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.
    Urbini M; Indio V; Tarantino G; Ravegnini G; Angelini S; Nannini M; Saponara M; Santini D; Ceccarelli C; Fiorentino M; Vincenzi B; Fumagalli E; Casali PG; Grignani G; Pession A; Ardizzoni A; Astolfi A; Pantaleo MA
    Genes Chromosomes Cancer; 2019 Sep; 58(9):636-642. PubMed ID: 30887595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case.
    Belinsky MG; Rink L; Cai KQ; Capuzzi SJ; Hoang Y; Chien J; Godwin AK; von Mehren M
    BMC Cancer; 2015 Nov; 15():887. PubMed ID: 26555092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways.
    Pantaleo MA; Nannini M; Corless CL; Heinrich MC
    Cancer Med; 2015 Jan; 4(1):101-3. PubMed ID: 25165019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
    Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
    JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors.
    Pantaleo MA; Ravegnini G; Astolfi A; Simeon V; Nannini M; Saponara M; Urbini M; Gatto L; Indio V; Sammarini G; Santini D; Ferracin M; Negrini M; Hrelia P; Biasco G; Angelini S
    Epigenomics; 2016 Oct; 8(10):1347-1366. PubMed ID: 27625077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.
    Italiano A; Chen CL; Sung YS; Singer S; DeMatteo RP; LaQuaglia MP; Besmer P; Socci N; Antonescu CR
    BMC Cancer; 2012 Sep; 12():408. PubMed ID: 22974104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST).
    Nannini M; Urbini M; Astolfi A; Biasco G; Pantaleo MA
    J Transl Med; 2017 May; 15(1):113. PubMed ID: 28535771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. qPCR in gastrointestinal stromal tumors: Evaluation of reference genes and expression analysis of KIT and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL.
    Fassunke J; Blum MC; Schildhaus HU; Zapatka M; Brors B; Künstlinger H; Büttner R; Wardelmann E; Merkelbach-Bruse S
    BMC Mol Biol; 2010 Dec; 11():100. PubMed ID: 21171987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST.
    Urbini M; Astolfi A; Indio V; Nannini M; Schipani A; Bacalini MG; Angelini S; Ravegnini G; Calice G; Del Gaudio M; Secchiero P; Ulivi P; Gruppioni E; Pantaleo MA
    Sci Rep; 2020 Nov; 10(1):19829. PubMed ID: 33199729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
    Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
    Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
    Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.
    Janeway KA; Kim SY; Lodish M; Nosé V; Rustin P; Gaal J; Dahia PL; Liegl B; Ball ER; Raygada M; Lai AH; Kelly L; Hornick JL; ; O'Sullivan M; de Krijger RR; Dinjens WN; Demetri GD; Antonescu CR; Fletcher JA; Helman L; Stratakis CA
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):314-8. PubMed ID: 21173220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST.
    Astolfi A; Indio V; Nannini M; Saponara M; Schipani A; De Leo A; Altimari A; Vincenzi B; Comandini D; Grignani G; Secchiero P; Urbini M; Pantaleo MA
    Front Oncol; 2020; 10():504. PubMed ID: 32391261
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene.
    Indio V; Astolfi A; Tarantino G; Urbini M; Patterson J; Nannini M; Saponara M; Gatto L; Santini D; do Valle IF; Castellani G; Remondini D; Fiorentino M; von Mehren M; Brandi G; Biasco G; Heinrich MC; Pantaleo MA
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
    Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
    Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
    BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.
    Gasparotto D; Rossi S; Polano M; Tamborini E; Lorenzetto E; Sbaraglia M; Mondello A; Massani M; Lamon S; Bracci R; Mandolesi A; Frate E; Stanzial F; Agaj J; Mazzoleni G; Pilotti S; Gronchi A; Dei Tos AP; Maestro R
    Clin Cancer Res; 2017 Jan; 23(1):273-282. PubMed ID: 27390349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.
    Pantaleo MA; Astolfi A; Urbini M; Nannini M; Paterini P; Indio V; Saponara M; Formica S; Ceccarelli C; Casadio R; Rossi G; Bertolini F; Santini D; Pirini MG; Fiorentino M; Basso U; Biasco G;
    Eur J Hum Genet; 2014 Jan; 22(1):32-9. PubMed ID: 23612575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.